SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy

Background: Non-alcoholic fatty liver disease (NAFLD) has a high prevalence in obesity and its presence should be screened. Laparoscopic sleeve gastrectomy (LSG) is an effective treatment for obesity, but its effects on NAFLD are still to be firmly established. The diagnosis of non-alcoholic steatoh...

Descripció completa

Dades bibliogràfiques

Autors principals:	Silvia Bettini, Emanuel Bordigato, Gabriella Milan, Chiara Dal Pra’, Francesca Favaretto, Anna Belligoli, Marta Sanna, Roberto Serra, Mirto Foletto, Luca Prevedello, Luca Busetto, Giorgio Fassina, Roberto Vettor, Roberto Fabris
Format:	Artigo
Idioma:	Inglês
Publicat:	Karger Publishers 2019-05-01
Col·lecció:	Obesity Facts
Matèries:	Obesity Non-alcoholic fatty liver disease SCCA-IgM Prediabetes Diabetes Bariatric surgery
Accés en línia:	https://www.karger.com/Article/FullText/499717
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!